Investor Presentation Q1-Q3 2020

52 Investor presentation First nine months of 2020 Novo Nordisk® Global obesity market share, market growth, and US volume and value market Obesity market growth and Novo Nordisk market share Obesity market size and growth US obesity care market remains small at around USD 853 million 80% 60% 40% 20% 0% NN market share DKK billion TRX SU market share mUSD/value market share 60% -3% 100 900 10 10 63% 50% 1 80 60 40% 60 600 60 30% -18% 40 20% 40 300 55% 3% 63% 20 10% 20 -Market growth (right axis) 0% 0 Aug SaxendaⓇ Others Aug 2019 2020 Source: IQVIA, Aug 2020, Value MAT, all countries; IQVIA Xponent MAT, May 2020 and NSP MAT, May 2020. Volume 0 Value Generic Other branded AOM Saxenda

View entire presentation